26.18
-0.5(-1.87%)
Currency In USD
Address
5401 West Kennedy Boulevard
Tampa, FL 33609
United States of America
Phone
813 553 6680
Website
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
788
First IPO Date
February 03, 2011
| Name | Title | Pay | Year Born |
| Frank D. Lee | CEO & Director | 3.15M | 1968 |
| Shawn Cross | Chief Financial Officer | 566,787 | 1968 |
| Anthony Molloy | Chief Legal & Compliance Officer | 581,410 | 1974 |
| Kristen Williams | Chief Administrative Officer & Secretary | 1M | 1974 |
| Jonathan Slonin | Chief Medical Officer | 1.03M | 1975 |
| Lauren Bullaro Riker | Principal Accounting Officer & Senior Vice President of Finance | 1.95M | 1979 |
| Brendan Teehan | Chief Commercial Officer | 0 | 1969 |
| Christopher C. Young | Chief Manufacturing Officer | 0 | 1972 |
| Krys Corbett | Chief Business Officer | 0 | N/A |
| Susan Mesco | Head of Investor Relations | 0 | N/A |
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature only to targeted nerves. It also develops proprietary multivesicular liposome, a drug delivery technology that encapsulates drugs without altering their molecular structure. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.
